Ann: Quarterly Activities/Appendix 4C Cash Flow Report, page-13

i keep rereading the announcement looking for something tangible.

not much in it. all our questions still remain;

why so long for CEO - apparently we're very close.
why further testing of mice - apparently we need more conclusive data
still waiting on other countries to sign up to ATL...
At least our SP didn't get pumped prior, so we shouldn't drop.

Mid '24 still stands. for now.

So our wild conspiracies can continue - perhaps a CEO after the data is released on the combo therapy mode of action, or is that just a strategic delay.. with Sarepta's approval tied in... how fun.